Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
暂无分享,去创建一个
Justin H Lo | Sangeeta N. Bhatia | Sabine Hauert | Yin Ren | Yin Ren | S. Bhatia | S. Hauert | Justin H. Lo
[1] Ulo Langel,et al. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.
[2] Judy Lieberman,et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.
[3] Jill P. Mesirov,et al. Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 , 2012, Science Translational Medicine.
[4] M. Stoffel,et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.
[5] Erkki Ruoslahti,et al. Transtumoral targeting enabled by a novel neuropilin-binding peptide , 2012, Oncogene.
[6] R. Weissleder,et al. Enhancing Membrane Permeability by Fatty Acylation of Oligoarginine Peptides , 2004, Chembiochem : a European journal of chemical biology.
[7] Yong Wang,et al. Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras , 2006, Nature Biotechnology.
[8] Sebastian Maurer-Stroh,et al. Myristoylation of viral and bacterial proteins. , 2004, Trends in microbiology.
[9] David R. Liu,et al. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins , 2009, Proceedings of the National Academy of Sciences.
[10] Erkki Ruoslahti,et al. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. , 2008, Cancer research.
[11] S. Dowdy,et al. Protein transduction domain delivery of therapeutic macromolecules. , 2011, Current opinion in biotechnology.
[12] Erkki Ruoslahti,et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. , 2009, Cancer cell.
[13] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[14] R. Weissleder,et al. Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.
[15] Darrell J Irvine,et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. , 2007, Nano letters.
[16] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[17] S. Dowdy,et al. Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction , 2009, The Journal of Biological Chemistry.
[18] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[19] Erkki Ruoslahti,et al. A tumor-homing peptide with a targeting specificity related to lymphatic vessels , 2002, Nature Medicine.
[20] David A. Belsley,et al. Regression Analysis and its Application: A Data-Oriented Approach.@@@Applied Linear Regression.@@@Regression Diagnostics: Identifying Influential Data and Sources of Collinearity , 1981 .
[21] Seungpyo Hong,et al. The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .
[22] George A. Calin,et al. RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.
[23] A. Prochiantz,et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.
[24] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[25] G. Elliott,et al. Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.
[26] K. D. Zylan,et al. Article , 1996, Physiology & Behavior.
[27] W. W. Muir,et al. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity , 1980 .
[28] Daniel G. Anderson,et al. Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.
[29] J. Mesirov,et al. Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4 , 2012 .
[30] Jun Yao,et al. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. , 2006, Cancer research.
[31] Samit Shah,et al. Light-activated RNA interference. , 2005, Angewandte Chemie.
[32] Natalie A. Lissy,et al. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein , 1999, Nature Medicine.
[33] F. Szoka,et al. Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.
[34] M. Pooga,et al. Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.